Fig. 2From: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinomaKaplan–Meier curves of progression-free survival (PFS) and overall survival (OS), median OS was 27 months (blue), and median PFS was 15 months (red)Back to article page